Boskovitz, A., Ochiai, H., Okamura, T., Akabani, G., Carlin, S., Bigner, D. D., & Zalutsky, M. R. (2006). At-211-labeled trastuzumab: Evaluation of an alpha-particle emitting targeted radiotherapeutic for the treatment of breast carcinoma carcinomatous meningitis. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 33, S184–S184.

Boskovitz, A., H. Ochiai, T. Okamura, G. Akabani, S. Carlin, D. D. Bigner, and M. R. Zalutsky. “At-211-labeled trastuzumab: Evaluation of an alpha-particle emitting targeted radiotherapeutic for the treatment of breast carcinoma carcinomatous meningitis.” EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 33 (September 1, 2006): S184–S184.

Boskovitz A, Ochiai H, Okamura T, Akabani G, Carlin S, Bigner DD, et al. At-211-labeled trastuzumab: Evaluation of an alpha-particle emitting targeted radiotherapeutic for the treatment of breast carcinoma carcinomatous meningitis. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2006 Sep 1;33:S184–S184.

Boskovitz, A., et al. “At-211-labeled trastuzumab: Evaluation of an alpha-particle emitting targeted radiotherapeutic for the treatment of breast carcinoma carcinomatous meningitis.” EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol. 33, SPRINGER, Sept. 2006, pp. S184–S184.

Boskovitz A, Ochiai H, Okamura T, Akabani G, Carlin S, Bigner DD, Zalutsky MR. At-211-labeled trastuzumab: Evaluation of an alpha-particle emitting targeted radiotherapeutic for the treatment of breast carcinoma carcinomatous meningitis. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. SPRINGER; 2006 Sep 1;33:S184–S184.